Publications 2021

Ramberg H, Richardsen E, de Souza GA, Rakaee M, Stensland ME, Braadland PR, Nygard S, Ogren O, Guldvik IJ, Berge V, Svindland A, Tasken KA, Andersen S (2021)
Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
Carcinogenesis, 42 (5), 685-693
DOI 10.1093/carcin/bgab015

Publications 2020

Guldvik IJ, Zuber V, Braadland PR, Grytli HH, Ramberg H, Lilleby W, Thiede B, Zucknick M, Saatcioglu F, Gislefoss R, Kvale R, George A, Gronberg H, Wiklund F, Neal DE, Gnanapragasam VJ, Tasken KA, Mills IG (2020)
Identification and Validation of Leucine-rich alpha-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification
Eur. Urol. Open Sci., 21, 51-60
DOI 10.1016/j.euros.2020.08.007

Serguienko A, Braadland P, Meza-Zepeda LA, Bjerkehagen B, Myklebost O (2020)
Accurate 3-gene-signature for early diagnosis of liposarcoma progression
Clin. Sarcoma Res., 10 (1), 4
DOI 10.1186/s13569-020-0126-1

Publications 2019

Braadland PR, Ramberg H, Grytli HH, Urbanucci A, Nielsen HK, Guldvik IJ, Engedal A, Ketola K, Wang WZ, Svindland A, Mills IG, Bjartell A, Tasken KA (2019)
The beta(2)-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
Mol. Cancer Res., 17 (11), 2154-2168
DOI 10.1158/1541-7786.MCR-18-0605

Braadland PR, Urbanucci A (2019)
Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer
Endocr.-Relat. Cancer, 26 (4), R211-R235
DOI 10.1530/ERC-18-0579

Publications 2017

Braadland PR, Giskeodegard G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnaes KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygard S, Berge V, Tasken KA, Tessem MB (2017)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br. J. Cancer, 117 (11), 1656-1664
DOI 10.1038/bjc.2017.346

Publications 2016

Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang WZ, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Maelandsmo GM, Svindland A, Barbier O, Tasken KA (2016)
Low beta(2)-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
Oncotarget, 7 (2), 1878-1894
DOI 10.18632/oncotarget.6479

Publications 2015

Braadland PR, Ramberg H, Grytli HH, Tasken KA (2015)
beta-adrenergic receptor signaling in prostate cancer
Front. Oncol., 4, 375
DOI 10.3389/fonc.2014.00375